Value-unlocking a key market theme in H1 2021

AT the beginning of 2021, this column expressed optimism about the market and suggested that it was time for investors to widen and increase their exposure to stocks.

It was a terribly easy call.

By then, it was clear that Covid-19 vaccines were on their way - in fact, Singapore had received its first shipment of the Pfizer-BioNTech vaccine the previous month - and that global economic activity was recovering.